Neuroendocrine correlates of depression in abstinent heroin-dependent subjects

Psychiatry Research

Volumn 96, Issue 3, 2000, Pages 221-234

  Gerra, Gilberto ^a   Zaimovic, Amir ^a   Zambelli, Ursula ^a   Delsignore, Roberto ^b   Baroni, M C ^b   Laviola, Giovanni ^c   Macchia, Teodora ^c   Brambilla, Francesca ^d  

^a AUSL   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Divisione di Medicina II   (Italy)

Author keywords

Depression; Dopamine; Heroin; Noradrenaline; Serotonin

Indexed keywords

BROMOCRIPTINE MESILATE; CLONIDINE; DEXFENFLURAMINE; DIAMORPHINE; DOPAMINE; GROWTH HORMONE; HYDROCORTISONE; NALOXONE; NALTREXONE; NORADRENALIN; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEROIN DEPENDENCE; HORMONE RESPONSE; HUMAN; MALE; MENTAL DISEASE; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROVOCATION TEST; SEROTONINERGIC SYSTEM;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRAIN; BROMOCRIPTINE; CASE-CONTROL STUDIES; CLONIDINE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DOPAMINE; DOPAMINE AGONISTS; FEMALE; FENFLURAMINE; HEROIN DEPENDENCE; HUMANS; MALE; NOREPINEPHRINE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SUBSTANCE ABUSE DETECTION;

EID: 0034694126     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00192-X     Document Type: Article

References (49)

1. Atypical depression: Clinical aspects and noradrenergic function
2. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans
3. Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers
4. Lisuride-induced stimulation of growth hormone release and inhibition of prolactin secretion in heroin-addicted subjects and controls
5. Dopamine and depression
6. Assessment of serotonergic function in major depression using D-fenfluramine: Relation to clinical variables and antidepressant response
7. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors
8. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers
9. 2-adrenoreceptor agonist binding sites in the postmortem brain of heroin addicts
10. 2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine
11. 2-Adrenoreceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder
12. 2-Adrenoreceptor subsensitivity in siblings of opioid addicts with personality disorders and depression
13. Serotonin function in detoxified heroin abusers: Prolactin and cortisol responses to fenfluramine challenge
14. Hostility in heroin abusers subtypes: Fluoxetine and naltrexone treatment
15. Clonidine and opiate receptor antagonists in the treatment of heroin addiction
16. Serotonergic function in mothers of opioid addicts: Correlation with comorbid depression
17. GABAergic function in detoxified heroin addicts: Relationship to anxiety disorders
18. Rapid opiate detoxication in outpatient treatment: Relationship with naltrexone compliance
19. The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences
20. A rating scale for depression
21. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?
22. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients
23. 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine
24. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons
25. Role of the dopaminergic system in depression
26. D-, L- and DL-Fenfluramine cause long-lasting depletions of serotonin in rat brain
27. The role of noradrenaline in depression: A review
28. 3H]imipramine binding in heroin and cocaine addicts
29. Influence of concurrent heroin and cocaine abuse on the adrenergic and serotonergic systems in man
30. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis
31. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: Importance of dose, species and drug
32. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men
33. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects
34. 2-Adrenergic receptor function in depression. The cortisol response to yohimbine
35. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats
36. Serotonergic dysfunction in addiction: Effects of alcohol, cigarette smoking and heroin on platelet 5-HT content
37. Selective genotyping for the role of 5-HT(2A), 5-HT(2C), and GABA α6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study
38. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - Postmortem evidence for decreased serotonin activity
39. Evidence for an association between heroin dependence and a VNTR polymorphism at the serotonin transporter locus
40. Dopamine D3 receptor gene polymorphism and alcohol dependence: Relation to personality rating
41. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
42. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetic, dose response, regional specificity and time course data